(1) Lucchinetti C, Bruck W, Parisi J, Scheithauer B,Rodriguez M and Lassmann H. Heterogeneityof multiple sclerosis lesions: implications for thepathogenesis of demyelination. Ann. Neurol. (2000)47: 707-17.
(2) Gudi V, Moharregh-Khiabani D, Skripuletz T,Koutsoudaki PN, Kotsiari A, Skuljec J, Trebst C andStangel M. Regional differences between grey andwhite matter in cuprizone induced demyelination.Brain Res. (2009) 1283: 127-38.
(3) Morell P, Barrett CV, Mason JL, Toews AD,Hostettler JD, Knapp GW and Matsushima GK.Gene expression in brain during cuprizone-induced
demyelination and remyelination. Mol. CellNeurosci. (1998) 12: 220-7.
(4) Matsushima GK and Morell P. The neurotoxicant,cuprizone, as a model to study demyelination andremyelination in the central nervous system. Brainpathol. (Zurich, Switzerland) (2001) 11:107-16.
(5) Hewlings SJ and Kalman DS. Curcumin: A Reviewof Its’ Effects on Human Health. Foods (2017) 6.
(6) Dai W, Wang H, Fang J, Zhu Y, Zhou J, Wang X,Wang, X. Zhou, Y and Zhou, M. Curcumin providesneuroprotection in model of traumatic brain injuryvia the Nrf2-ARE signaling pathway. Brain Res.Bull. (2018) 140: 65-71.
(7) Randino R, Grimaldi M, Persico M, De Santis A, CiniE, Cabri W, Riva Antonella, D’Errico G, FattorussoC, D’Ursi A and Rodriquez M. Investigating theNeuroprotective Effects of Turmeric Extract:Structural Interactions of β-Amyloid Peptide withSingle Curcuminoids. Sci. Rep. (2016) 6:38846.
(8) Kunnumakkara AB, Bordoloi D, Padmavathi G,Monisha J, Roy NK, Prasad S and Aggarwal, B.Curcumin, the golden nutraceutical: multitargetingfor multiple chronic diseases. Br. J. Pharmacol.(2017) 174: 1325-48.
(9) Mohajeri M, Sadeghizadeh M, Najafi F and Javan M.Polymerized nano-curcumin attenuates neurologicalsymptoms in EAE model of multiple sclerosisthrough down regulation of inflammatory andoxidative processes and enhancing neuroprotectionand myelin repair. Neuropharmacology (2015) 99:156-67.
(10) Ferrari E, Pignedoli F, Imbriano C, MarvertiG, Basile V, Venturi E and Saladini, M. Newlysynthesized curcumin derivatives: crosstalk betweenchemico-physical properties and biological activity.J. Med. Chem. (2011) 54: 8066-77.
(11) I. Mahran R, Hagras M, Sun D, E and Brenner D.Bringing Curcumin to the Clinic in Cancer Prevention:a Review of Strategies to Enhance Bioavailability andEfficacy. AAPS J. (2017) 19:54-81.
(12) Sarbolouki MN, Sadeghizadeh M, Yaghoobi MM,Karami A and Lohrasbi T. Dendrosomes: a novelfamily of vehicles for transfection and therapy. J.Chem. Technol. Biotechnol. (2000) 75: 919-22.
(13) Sadeghizadeh M, Ranjbar B, Damaghi M, KhakiL, Sarbolouki MN, Najafi F, Parsaee, S, Ziaee A-A,Massumi M, Lubitz W, Kudela, P, Paukner andKarami A. Dendrosomes as novel gene porters-III. J.Chem. Technol. Biotechnol. (2008) 83: 912-20.
(14) Pourasgari F, Ahmadian S, Salmanian AH,Sarbolouki MN and Massumi M. Low cytotoxicityeffect of dendrosome as an efficient carrier forrotavirus VP2 gene transferring into a human lungcell line : dendrosome, as a novel intranasally geneporter. Mol. Biol. Rep. (2009) 36: 105-9.
(15) Mahjoub MA, Bakhshinejad B, SadeghizadehM and Babashah S. Combination treatment withdendrosomal nanocurcumin and doxorubicinimproves anticancer effects on breast cancer cells 319Motavaf M et al. / IJPR (2020), 19 (3): 310-320through modulating CXCR4/NF-kappaB/Smoregulatory network. Mol. Biol. Rep. (2017) 44: 341-51.
(16) Montazeri M, Pilehvar-Soltanahmadi Y,Mohaghegh M, Panahi A, Khodi S, Zarghami N andSadeghizadeh M. Antiproliferative and ApoptoticEffect of Dendrosomal Curcumin Nanoformulationin P53 Mutant and Wide-Type Cancer Cell Lines.Anticancer Agents Med. Chem. (2017) 17: 662-73.
(17) Chamani F, Sadeghizadeh M, Masoumi M andBabashah S. Evaluation of MiR-34 Family andDNA Methyltransferases 1, 3A, 3B Gene ExpressionLevels in Hepatocellular Carcinoma FollowingTreatment with Dendrosomal Nanocurcumin. AsianPac. J. Cancer. Prev. (2016) 17: 219-24.
(18) Dehghan Esmatabadi MJ, Farhangi B, SafariZ, Kazerooni H, Shirzad H, Zolghadr F andSadeghizadeh M. Dendrosomal curcumin inhibitsmetastatic potential of human SW480 colon cancercells through Down-regulation of Claudin1, Zeb1and Hef1-1 gene expression. Asian Pac. J. CancerPrev. (2015) 16: 2473-81.
(19) Tahmasebi Mirgani M, Isacchi B, SadeghizadehM, Marra F, Bilia AR, Mowla SJ, Najafi F andBabaei E. Dendrosomal curcumin nanoformulationdownregulates pluripotency genes via miR-145activation in U87MG glioblastoma cells. Int. J.Nanomed. (2014) 9: 403-17.
(20) Babaei E, Sadeghizadeh M, Hassan ZM, Feizi MA,Najafi F and Hashemi SM. Dendrosomal curcuminsignificantly suppresses cancer cell proliferation invitro and in-vivo. Int. Immunopharmacol. (2012) 12:226-34.
(21) Alizadeh AM, Khaniki M, Azizian S, MohaghgheghiMA, Sadeghizadeh M and Najafi F. Chemopreventionof azoxymethane-initiated colon cancer in rat byusing a novel polymeric nanocarrier--curcumin. Eur.J. Pharmacol. (2012) 689: 226-32.
(22) Bakker D and Ludwin S. Blood-brainbarrier permeability during Cuprizone-induceddemyelination. Implications for the pathogenesisof immune-mediated demyelinating diseases. J.Neurol. Sci. (1987) 78: 125-37.
(23) Gou M, Men K, Shi H, Xiang M, Zhang J, SongJ, Long J, Wan Y, Luo F, Zhao X and Qian, Z.Curcumin-loaded biodegradable polymeric micellesfor colon cancer therapy in-vitro and in-vivo.Nanoscale (2011) 3: 1558-67.
(24) Akbari E, Akhavan O, Hatamie S and Rahighi R.Curcumin as a green fluorescent label to revive thefluorescence property of functionalized grapheneoxide nanosheets. JDDST (2018) 45: 422-7.
(25) Bhopate DP, Mahajan PG, Garadkar KM, KolekarGB and Patil SR. A highly selective and sensitivesingle click novel fluorescent off–on sensor forcopper and sulfide ions detection directlyin aqueoussolution using curcumin nanoparticles. New J. Chem.
(2015) 39: 7086-96.
(26) Ghosh M, Singh AT, Xu W, Sulchek T, Gordon LIand Ryan RO. Curcumin nanodisks: formulation andcharacterization. Nanomedicine (2011) 7: 162-7.
(27) Xie M, Tobin JE, Budde MD, Chen CI, TrinkausK, Cross AH, Mingqiang X, Sheng-Kwei S andRegina C. Rostrocaudal analysis of corpus callosumdemyelination and axon damage across diseasestages refines diffusion tensor imaging correlationswith pathological features. J. Neuropathol. Exp.Neurol. (2010) 69: 704-16.
(28) Steelman AJ, Thompson JP and Li J. Demyelinationand remyelination in anatomically distinct regionsof the corpus callosum following cuprizoneintoxication. Neurosci. Res. (2012) 72: 32-42.
(29) Niknam P, Raoufy MR, Fathollahi Y and JavanM. Modulating proteoglycan receptor PTPσ usingintracellular sigma peptide improves remyelinationand functional recovery in mice with demyelinatedoptic chiasm. Mol. Cell. Neurosci. (2019) 99:103391.
(30) Yazdi A, Baharvand H and Javan M. Enhancedremyelination following lysolecithin-induceddemyelination in mice under treatment withfingolimod (FTY720). Neuroscience (2015) 311: 34-44.
(31) Barnett MH and Prineas JW. Relapsing andremitting multiple sclerosis: pathology of the newly
forming lesion. Ann. Neurol. (2004) 55: 458-68.
(32) Ren Z, Wang Y, Tao D, Liebenson D, Liggett T,Goswami R, Clarke R, Stefoski D, and BalabanovR. Overexpression of the dominant-negative formof interferon regulatory factor 1 inoligodendrocytesprotects against experimental autoimmuneencephalomyelitis. J. Neurosci. (2011) 31: 8329-41.
(33) Hisahara S, Araki T, Sugiyama F, Yagami K, SuzukiM, Abe K, Yamamura K, Miyazaki K, Momoi J,Saruta T, Bernard CC, Okano H and Miura M.Targeted expression of baculovirus p35 caspaseinhibitor in oligodendrocytes protects mice againstautoimmune-mediated demyelination. EMBO. J.(2000) 19: 341-8.
(34) Linker RA, Maurer M, Gaupp S, Martini R,Holtmann B, Giess R, Rieckmann P, LassmannH, Toyka K, Sendtner M and Gold R. CNTF isa major protective factor in demyelinating CNSdisease: a neurotrophic cytokine as modulator inneuroinflammation. Nature Med. (2002) 8: 620-4.
(35) Adomakp-Bonsu A, Pratten M, Fry J and Chan S.Hepatoprotection by curcumin and sulforaphane
against tBHP-induced oxidative damage. Planta.Med. (2014) 80:P2Y20.
320Myelin Protection by a Nano-Formulation of Curcumin
(36) Yu H, Ma L, Jiang J and Sun S. Protective effectof curcumin on neural myelin sheaths by attenuatinginteractions between the endoplasmic reticulum andmitochondria after compressed spinal cord. J Spine(2016) 5: 1-6.
(37) He LF, Chen HJ, Qian LH, Chen GY and BuzbyJS. Curcumin protects pre-oligodendrocytes fromactivated microglia in-vitro and in-vivo. Brain Res.(2010) 1339: 60-9.
(38) Wang YF, Zu JN, Li J, Chen C, Xi CY and YanJL. Curcumin promotes the spinal cord repair viainhibition of glial scar formation and inflammation.Neurosci. Lett. (2014) 560:51-6.
(39) Qureshi M, Al-Suhaimi EA, Wahid F, Shehzad Oand Shehzad A. Therapeutic potential of curcuminfor multiple sclerosis. Neurol. Sci.(2018) 39: 207-14.
(40) Naeimi R, Safarpour F, Hashemian M, TashakorianH, Ahmadian SR, Ashrafpour M and GhasemiKasman M. Curcumin-loaded nanoparticlesameliorate glial activation and improve myelinrepair in lyolecithin-induced focal demyelinationmodel of rat corpus callosum. Neurosci. Lett. (2018)674: 1-10.